BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2006
View Archived Issues
Novel treatment strategies for cancer covered in recent patent literature
Read More
Recent patents describe new analgesic agents
Read More
Recent patents describe novel agents for anxiety, depression, psychosis etc.
Read More
Recent Universitaetsklinikum Muenster patent discloses novel diagnostic agents
Read More
Amoxicillin PULSYS demonstrates bacterial eradication in adults and adolescents
Read More
Visual acuity stabilization eight weeks after a single dose of Sirna-027
Read More
RabiCide to enter preclinical testing for rabies by 2007
Read More
Acrux and Population Council amend transdermal contraceptive agreement
Read More
Novartis, Schering-Plough to develop once-daily therapy for asthma and COPD
Read More
Additional information for Herceptin sBLA deemed major amendment
Read More
Gilead completes acquisition of Corus Pharma
Read More
Genzyme seeks to expand European label of Synvisc
Read More
Pharmexa discontinues phase II study of HER-2 Protein AutoVac
Read More
Approvable letter for eprodisate for AA amyloidosis
Read More
Delta opioid agonist provides effective analgesia in preclinical bone cancer pain
Read More
Jak2 validated as a therapeutic target for CML
Read More
Phase IIa asthma study of LAB CGRP completes enrollment
Read More
Nastech studies PYY3-36 nasal spray in dose-ranging obesity study
Read More
Depomed completes phase I study with GERD compound
Read More
DG-051 enters phase I for prevention of heart attack
Read More
Phase II trial studies Iomai's vaccine patch for travelers' diarrhea
Read More
Targeting 5-HT2A receptor-mediated nociception relieves painful symptoms following tissue injury
Read More
PI3Kdelta inhibition with IC-87114 has shown benefit in a murine model of allergic asthma
Read More
Galvus filed for European approval in type 2 diabetes
Read More
Soltamox launched in the U.S.
Read More